Suppr超能文献

面向非洲下一代监管科学家的需求驱动型人才和能力发展。

Needs-driven talent and competency development for the next generation of regulatory scientists in Africa.

机构信息

South African Health Products Regulatory Authority, Pretoria, Gauteng, South Africa.

Medicines Control Authority of Zimbabwe, Harare, Zimbabwe.

出版信息

Br J Clin Pharmacol. 2022 Feb;88(2):579-586. doi: 10.1111/bcp.15020. Epub 2021 Aug 24.

Abstract

Capacity building programmes for African regulators should link education, training and research with career development in an approach that combines an academic base and experiential learning aligned within a competency framework. A regulatory ecosystem that engages with a broad range of stakeholders will mean that expertise in the ever-expanding field of regulatory science filters into teaching and research in a symbiotic way. In this way capacity development interventions will be a collaborative approach between the learning context (academic and training institutions) and the performance context (regulatory agencies and industry), which will ultimately best serve the patients. Monitoring and evaluation of capacity development interventions will be essential to show value of investments and ultimately guide continued funding and sustainability. This paper reviews the skills and human capacity gaps, reports on regulatory assessment pathways used in Ghana, South Africa and Zimbabwe and outlines a staged tactical approach for Africa that builds on previous efforts to strengthen African regulatory ecosystems.

摘要

应当将教育、培训和研究与职业发展联系起来,以一种结合学术基础和经验学习并与能力框架相一致的方法来为非洲监管机构制定能力建设方案。一个与广泛利益攸关方互动的监管生态系统意味着监管科学这一不断扩展领域的专业知识将以共生的方式融入教学和研究中。通过这种方式,能力发展干预措施将成为学习环境(学术和培训机构)与绩效环境(监管机构和行业)之间的合作方法,这最终将为患者提供最佳服务。对能力发展干预措施进行监测和评估对于展示投资价值以及最终指导持续供资和可持续性至关重要。本文审查了技能和人力资源能力差距,报告了加纳、南非和津巴布韦使用的监管评估途径,并概述了一个分阶段的策略方法,该方法以加强非洲监管生态系统的先前努力为基础。

相似文献

1
Needs-driven talent and competency development for the next generation of regulatory scientists in Africa.
Br J Clin Pharmacol. 2022 Feb;88(2):579-586. doi: 10.1111/bcp.15020. Epub 2021 Aug 24.
6
Collaboration on evidence synthesis in Africa: a network study of growing research capacity.
Health Res Policy Syst. 2021 Sep 19;19(1):126. doi: 10.1186/s12961-021-00774-2.
7
The future of Cochrane Neonatal.
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
9
Partnership for mental health development in Sub-Saharan Africa (PaM-D): a collaborative initiative for research and capacity building.
Epidemiol Psychiatr Sci. 2019 Aug;28(4):389-396. doi: 10.1017/S2045796018000707. Epub 2018 Nov 27.

引用本文的文献

2
Mitigating inequitable access to appropriate antibiotics in low- and middle-income countries.
JAC Antimicrob Resist. 2025 Apr 24;7(2):dlaf061. doi: 10.1093/jacamr/dlaf061. eCollection 2025 Apr.
3
Editorial: Education and training in pharmaceutical medicine, medicines development and regulation for scientists worldwide.
Front Pharmacol. 2025 Mar 18;16:1544678. doi: 10.3389/fphar.2025.1544678. eCollection 2025.
4
Advancing pharmacometrics in Africa-Transition from capacity development toward job creation.
CPT Pharmacometrics Syst Pharmacol. 2025 Mar;14(3):407-419. doi: 10.1002/psp4.13291. Epub 2024 Dec 9.
5
Drug outcomes research and policies - trends and challenges.
Front Pharmacol. 2024 Aug 26;15:1476849. doi: 10.3389/fphar.2024.1476849. eCollection 2024.
6
Innovation in laboratory testing approaches to oversee Africa's local production of medical products.
Int Health. 2024 Mar 4;16(2):129-132. doi: 10.1093/inthealth/ihad053.
7
Collaborative training of regulators as an approach for strengthening regulatory systems in LMICs: experiences of the WHO and Swissmedic.
Front Med (Lausanne). 2023 May 18;10:1173291. doi: 10.3389/fmed.2023.1173291. eCollection 2023.
8
Development of a checklist for the assessment of pharmacovigilance guidelines in Southern Africa: a document review.
Ther Adv Drug Saf. 2023 Jan 24;14:20420986221143272. doi: 10.1177/20420986221143272. eCollection 2023.

本文引用的文献

1
Evaluation of the Regulatory Review Process in Zimbabwe: Challenges and Opportunities.
Ther Innov Regul Sci. 2021 May;55(3):474-489. doi: 10.1007/s43441-020-00242-z. Epub 2021 Jan 2.
2
Evaluating the Success of ZaZiBoNa, the Southern African Development Community Collaborative Medicines Registration Initiative.
Ther Innov Regul Sci. 2020 Nov;54(6):1319-1329. doi: 10.1007/s43441-020-00154-y. Epub 2020 Apr 29.
4
Eight years of the East African Community Medicines Regulatory Harmonization initiative: Implementation, progress, and lessons learned.
PLoS Med. 2020 Aug 12;17(8):e1003134. doi: 10.1371/journal.pmed.1003134. eCollection 2020 Aug.
5
Scientific considerations for global drug development.
Sci Transl Med. 2020 Jul 29;12(554). doi: 10.1126/scitranslmed.aax2550.
6
Evolution of the Development of Core Competencies in Pharmaceutical Medicine and Their Potential Use in Education and Training.
Front Pharmacol. 2020 Mar 19;11:282. doi: 10.3389/fphar.2020.00282. eCollection 2020.
7
The European Medicines Agency facilitates access to medicines in low- and middle-income countries.
Expert Rev Clin Pharmacol. 2020 Mar;13(3):321-325. doi: 10.1080/17512433.2020.1724782. Epub 2020 Feb 13.
8
The Creation of a Competent Global Regulatory Workforce.
Front Pharmacol. 2019 Mar 19;10:181. doi: 10.3389/fphar.2019.00181. eCollection 2019.
9
The South African Regulatory System: Past, Present, and Future.
Front Pharmacol. 2018 Dec 4;9:1407. doi: 10.3389/fphar.2018.01407. eCollection 2018.
10
The Regulatory Review Process in South Africa: Challenges and Opportunities for a New Improved System.
Ther Innov Regul Sci. 2018 Jul;52(4):449-458. doi: 10.1177/2168479018776649. Epub 2018 May 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验